Content about Sanofi-Aventis

August 30, 2011
Federal court issues rulings in favor of Teva in MS drug case

A federal court has acted in favor of Teva Pharmaceutical Industries in the drug maker's patent infringement case against several generic drug companies seeking to market versions of its multiple sclerosis drug.

August 23, 2011
Sandoz announces FDA approval, U.S. launch of chemotherapy drug

The Food and Drug Administration has approved a chemotherapy drug made by Sandoz, the drug maker said Tuesday.

August 12, 2011
Mylan ships generic prostate drug

Generic drug maker Mylan has begun shipping a drug for enlarged prostate, the company said Friday.

August 10, 2011
Sanofi launches Facebook contest promoting Allegra

Sanofi on Wednesday announced the introduction of Allegra's new Allergy Adventures contest on Facebook. Allergy sufferers are invited to upload a short video showing their daily challenges with allergies for a chance to win $5,000 toward a vacation package.

August 4, 2011
NASN, Sanofi Pasteur team up to raise awareness of meningitis

Meningococcal meningitis is rare but can kill preteens and teenagers in as little as a day. Yet many kids still engage in behaviors that put them at risk of contracting the disease despite not being vaccinated.

July 28, 2011
Sanofi announces executive changes

The president and CEO of Sanofi's U.S. operations is stepping into a newly created role at the drug maker.

July 21, 2011
Brilinta receives FDA approval

The Food and Drug Administration has approved a drug made by AstraZeneca to reduce the rate of heart attacks in patients with acute coronary syndrome, the Anglo-Swedish drug maker said.

July 20, 2011
Valeant inks distribution agreement for Zuacta in Canada

Canadian drug maker Valeant Pharmaceuticals International has signed an agreement with Sanofi’s subsidiary in Canada to distribute a topical medication for osteoarthritis in the country.

July 18, 2011
Sanofi begins shipping flu vaccine for 2011-2012 season

Sanofi Pasteur, the vaccines division of Sanofi, on Monday announced that it has begun shipping its 2011-2012 Fluzone influenza virus vaccine in the United States.

July 14, 2011
Sanofi sells skin care business to Valeant Pharmaceuticals International

French drug maker Sanofi has sold its skin care business to Canada’s Valeant Pharmaceuticals International, Sanofi said.

June 16, 2011
Sanofi, Audion enter research collaboration for hearing loss treatments

French drug maker Sanofi has entered a collaboration with Audion Therapeutics to develop treatments for hearing loss.

June 7, 2011
Actavis granted final approval for generic Ambien CR

The Food and Drug Administration has given final approval to a generic drug for insomnia made by Actavis, the drug maker said Monday.

June 6, 2011
Sanofi Pasteur donates tetanus-containing vaccine doses to storm victims

The vaccines division of drug maker Sanofi donated vaccine doses on behalf of the Jeff Gordon Children's Foundation to Direct Relief International, which will aid victims of the recent storms in the Southeast and Midwest.

May 31, 2011
Sanofi: Lyxumia won't significantly increase hypoglycemia risk

New results from a late-stage clinical trial of a Sanofi drug for Type 2 diabetes indicated that the drug can reduce blood sugar in patients without increasing the risk of causing the blood sugar levels to dip too low, the French drug maker said Tuesday.

May 10, 2011
FDA OKs Sanofi Pasteur's Fluzone Intradermal

Sanofi’s vaccines division has won Food and Drug Administration approval for a vaccine designed for injection into the skin, the company said Tuesday.

May 9, 2011
Sanofi bids adieu to Aventis moniker

French drug maker Sanofi-Aventis has shortened its name to Sanofi, the company said.

May 4, 2011
Report: Novartis to boost biosimilars portfolio

Novartis is making big investments in biosimilars, CEO Joe Jimenez said in an interview with Fortune magazine.

April 29, 2011
Allegra captures strong sales

Sanofi-Aventis on Thursday reported strong sales out of the gate for its recently switched second-generation antihistamine Allegra.

April 29, 2011
Zytiga OKed as prostate cancer treatment

The Food and Drug Administration has approved a new treatment for prostate cancer made by Johnson & Johnson.

April 27, 2011
Investigational drug, in combo with chemo, shown to help colorectal cancer patients survive longer

An investigational drug helped patients survive longer when combined with chemotherapy as a second-line treatment for colorectal cancer that had spread to other parts of the body, according to results of a late-stage clinical trial announced by French drug maker Sanofi-Aventis and U.S.-based Regeneron Pharmaceuticals.

April 25, 2011
Menactra approved for use in infants, toddlers

The Food and Drug Administration has approved the first vaccine for preventing meningococcal disease in children as young as 9 months old, the agency said.

April 25, 2011
Retailers, consumers seeing purple

Customers are seeing purple again — reminiscent of another switch that took advantage of the eye-catching color purple. Sanofi-Aventis through its Chattem division in March launched Allegra, the last of the second-generation antihistamines. And purple-powered displays, like this in a Walmart in Lancaster, Pa., dotted the retail pharmacy landscape.


April 21, 2011
Merck, Sanofi commence late-stage trial for childhood diseases vaccine

Merck and Sanofi Pasteur have started a late-stage clinical trial of a combination vaccine for six childhood diseases, the companies said Thursday.

April 18, 2011
Study: Drug-drug interaction warning letters work

A letter educating healthcare providers regarding a drug-drug interaction between prescription anticlotting drug Plavix (clopidogrel) and a proton-pump inhibitor has resulted in a reduction in the number of patients combining the two therapies, according to a new study by Prime Therapeutics released Monday.

April 14, 2011
Dr. Reddy's announces market launch of generic OTC Allegra

The Food and Drug Administration has approved Dr. Reddy's version of an allergy medication that recently received Rx-to-OTC switch approval, the generic drug maker said.

© 2013 Drug Store News. All Rights Reserved.